Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance

Neuroscience Letters

Volumn 397, Issue 1-2, 2006, Pages 1-4

  Tang, Lei ^a   Shukla, Pradeep K ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Analgesia; CaMKII; Phosphorylation; Tolerance; Trifluoperazine

Indexed keywords

OPIATE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; TRIFLUOPERAZINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DRUG INTERACTIONS; DRUG TOLERANCE; ENZYME INHIBITORS; MALE; MICE; MICE, INBRED ICR; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; PAIN MEASUREMENT; REACTION TIME; SPINAL CORD; TRIFLUOPERAZINE;

EID: 33644779832     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.11.050     Document Type: Article

References (26)

1. E.J. Bilsky, R.N. Bernstein, Z. Wang, W. Sadee, and F. Porreca Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice J. Pharmacol. Exp. Ther. 277 1996 484 490
2. I. Bruggemann, S. Schulz, D. Wiborny, and V. Hollt Colocalization of the mu-opioid receptor and calcium/calmodulin- dependent kinase II in distinct pain-processing brain regions Brain Res. Mol. Brain Res. 85 2000 239 250
3. G.H. Fan, L.Z. Wang, H.C. Qiu, L. Ma, and G. Pei Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence Mol. Pharmacol. 56 1999 39 45
4. V. Granados-Soto, I. Kalcheva, X. Hua, A. Newton, and T.L. Yaksh Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion Pain 85 2000 395 404
5. A.L. Green Differential effects on mouse brain catecholamine turnover of chlorpromazine, trifluoperazine and closely-related non-tranquillizing analogues J. Pharm. Pharmacol. 25 1973 267 269
6. 2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function Annu. Rev. Biochem. 71 2002 473 510
7. T. Koch, T. Kroslak, P. Mayer, E. Raulf, and V. Hollt Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin- dependent protein kinase II in agonist-mediated desensitization J. Neurochem. 69 1997 1767 1770
8. J.H. Liang, X.F. Ye, H.L. Sun, Y. Lu, and P. Xu Trifluoperazine attenuates naloxone-precipitated symptoms in morphine-dependent rats and mice Chin. Pharmacol. Bull. 17 2001 458 462
9. J. Mao, D.D. Price, and D.J. Mayer Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions Pain 62 1995 259 274
10. A. Mestek, J.H. Hurley, L.S. Bye, A.D. Campbell, Y. Chen, M. Tian, J. Liu, H. Schulman, and L. Yu The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C J. Neurosci. 15 1995 2396 2406
11. K.K. Midha, E.D. Korchinski, R.K. Verbeeck, R.M. Roscoe, E.M. Hawes, J.K. Cooper, and G. McKay Kinetics of oral trifluoperazine disposition in man Br. J. Clin. Pharmacol. 15 1983 380 382
12. G. Milner The effect of antidepressants and "tranquilizers" on the response of mice to ethanol Br. J. Pharmacol. 34 1968 370 376
13. M. Narita, Y. Feng, M. Makimura, B. Hoskins, and I.K. Ho A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception Eur. J. Pharmacol. 271 1994 543 545
14. R. Nehmad, H. Nadler, and R. Simantov Effects of acute and chronic morphine treatment of calmodulin activity of rat brain Mol. Pharmacol. 22 1982 389 394
15. S. Niu, C.H. Kuo, Y. Gan, E. Nishikawa, T. Sadakata, H. Ichikawa, and N. Miki Increase of calmodulin III gene expression by mu-opioid receptor stimulation in PC12 cells Jpn. J. Pharmacol. 84 2000 412 417
16. J.M. Quillan, K.W. Carlson, C. Song, D. Wang, and W. Sadee Differential effects of mu-opioid receptor ligands on Ca(2+) signaling J. Pharmacol. Exp. Ther. 302 2002 1002 1012
17. B.D. Roufogalis, A.M. Minocherhomjee, and A. Al-Jobore Pharmacological antagonism of calmodulin Can. J. Biochem. Cell Biol. 61 1983 927 933
18. i and adenylyl cyclase Br. J. Pharmacol. 120 1997 1165 1171
19. F.L. Smith, A.B. Lohmann, and W.L. Dewey Involvement of phospholipid signal transduction pathways in morphine tolerance in mice Br. J. Pharmacol. 128 1999 220 226
20. D. Wang, W. Sadee, and J.M. Quillan Calmodulin binding to G protein-coupling domain of opioid receptors J. Biol. Chem. 274 1999 22081 22088
21. Z. Wang, E.J. Bilsky, F. Porreca, and W. Sadee Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence Life Sci. 54 1994 L339 L350
22. Z. Wang, L.R. Gardell, M.H. Ossipov, T.W. Vanderah, M.B. Brennan, U. Hochgeschwender, V.J. Hruby, T.P. Malan Jr., J. Lai, and F. Porreca Pronociceptive actions of dynorphin maintain chronic neuropathic pain J. Neurosci. 21 2001 1779 1786
23. Z.J. Wang, L. Tang, and L. Xin Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II Eur. J. Pharmacol. 465 2003 199 200
24. J.R. Wardell Jr., and R.G. Staples III Animal studies comparing the neuropharmacological profile of a trifluoperazine HCl-amobarbital combination with that of the individual components Arch. Int. Pharmacodyn. Ther. 179 1969 106 120
25. X.F. Ye, Y. Lu, P. Zhang, and J.H. Liang Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats Eur. J. Pharmacol. 486 2004 265 271
26. K.P. Zeitz, A.B. Malmberg, H. Gilbert, and A.I. Basbaum Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice Pain 94 2001 245 253